CFPB Bans Excessive Credit Card Late Fees
In a bold move aimed at alleviating the burden on American consumers, the Consumer Financial Protection Bureau (CFPB) has finalized a groundbreaking rule to...
JetBlue Airways and Spirit Airlines Abandon $3.8 Billion Merger
The ambitious $3.8 billion merger between JetBlue Airways and Spirit Airlines has come to an abrupt end, sending shockwaves throughout the airline industry.
After weeks...
L3Harris To Pay $650K in 401(k) settlement
Defense behemoth L3Harris has pledged a hefty $650,000 to settle a class action lawsuit, culminating accusations of breaching federal benefits law. The lawsuit, spotlighting...
Ohio Agency Puts Discovery On Hold In FirstEnergy Probes
In a gripping turn of events, the Ohio utilities commission has slammed the brakes on discovery proceedings related to the sordid saga surrounding FirstEnergy...
Douglas Group Plans €1.1B Frankfurt Float
In a bold move set to shake the European beauty market, Douglas Group, a prominent beauty store owner, announced today its strategic intentions to...
JetBlue and Spirit Nix closed $3.8B merger
JetBlue Airways and Spirit Airlines have mutually agreed to scrap their planned $3.8 billion merger, following a federal court's blockage earlier this year. The...
EU Fines Apple $2 Billion In Spotify Antitrust Case
In a seismic jolt to the tech industry, the European Union's antitrust authority has levied a staggering fine of €1.8 billion ($1.95 billion) against...
Elon Musk Sues Sam Altman and OpenAI Over Prioritizing Profit Over Humanity
Elon Musk, billionaire entrepreneur and founder of Tesla and SpaceX filed a lawsuit Thursday against Sam Altman and OpenAI, claiming the company has abandoned...
Death of Angela Chao: Ongoing Criminal investigation, Not a Typical Accident
The circumstances surrounding the death of Angela Chao, 50, the CEO of Foremost Group, have raised the suspicions of law enforcement. Chao’s death is...
AstraZeneca Loses Challenge To Medicare Drug Price Program
A Delaware federal judge has dealt a significant blow to AstraZeneca, rejecting the pharmaceutical giant's challenge to the Medicare price negotiation program. The decision,...